Clinical and biochemical follow-up after radiation therapy for localized prostate carcinoma. (English).Serum PSA is an excellent marker of disease status after external beam radiotherapy or brachytherapy for patients with prostate carcinoma. A low PSA nadir≤1 even≤0.5ng/mL has been shown to be ...
Radiation therapy plays a central role in treatment strategies of cervical cancer. Follow-up after external pelvic radiation therapy and brachytherapy is b... KI Cao,R Mazeron,I Barillot - 《Cancer/radiothérapie》 被引量: 2发表: 2015年 Irradiation alone or in combination with surgery in stage...
Radiation therapy is a therapeutic option with curative intent for patients with prostate cancer. Monitoring of prostate-specific antigen (PSA) values is the current standard of care in the follow-up. Imaging is recommended only for symptomatic patients and/or for further therapeutic options.For ...
The use of the serum marker prostate-specific antigen () has altered drastically the follow-up after . is far superior to any other method of detecting recurrences after either radiation therapy or radical prostatectomy. Once the reaches a nadir level after radiation therapy or becomes undetectable...
3-year follow-up after intracoronary beta-radiation therapy for in-stent restenosis reveals considerable delayed recurrent restenosisE. IofinaP. RadkeR. LangenbergA. FrankeR. SchubertP. HanrathR. Hoffmann
To the Editor: In 1979, we reported the results of treating 19 patients who had acute myelogenous leukemia in first remission with intensive chemotherapy, radiation therapy, and transplantation of allogeneic marrow from HLA-identical siblings between March 1976 and March 1978.1 These patients had been...
Kinsella TJ, Trivette G, Rowland J, Sorace R, Miller R, Fraass B, Steinberg SM, Glatstein E, Sherins RJ (1989) Long-term follow-up of testicular function following radiation therapy for early-stage Hodgkin’s disease. J Clin Oncol 7(6):718–724...
Preoperative Radiation Therapy is an Independent and Strong Risk Factor for Late Non-cancer Death after Esophagectomy especially from the other causes than esophageal cancer in the follow-up period after esophagectomy.Method: All of 523 patients with esophageal carcinoma who... T Mori,S Miyazaki,G ...
While definitive intensity modulated radiation therapy (IMRT)-chemotherapy affords loco-regional control rates (LRC) of approximately 80% in advanced pharyngeal cancer, corresponding rates are reported to be much lower for OCC. The aim of this work was to evaluate loco-regional disease control and ...
Serological follow-up study on the antibody levels to Epstein-Barr virus-determined nuclear antigen (EBNA) patients with nasopharyngeal carcinoma (NPC) after radiation therapy Serological follow-up studies for up to 4 years on the levels of IgG antibody to EBV-determined nuclear antigen (EBNA) were...